MEDP
Medpace Holdings, Inc.
A contract research organization (CRO), Medpace runs the full span of clinical drug trials — from early safety tests to post-market studies — for small and mid-sized biopharma companies, including medical oversight, monitoring, labs, and regulatory work. Founded in Cincinnati in 1992 by Dr. August Troendle, a former FDA reviewer, it was originally called Medical Research Services; the name Medpace blends "medical" with "pace," reflecting its mission to speed trials along. It also built its own software, ClinTrak, to track studies in real time, and keeps its central labs and a Phase I unit on its own Cincinnati campus.
CUSIP: 58506Q109HealthcareUS5 holders
Total Value
$248.72M
Total Shares
469.7K
Net Share Change
-37.0K
Activity
1 buying3 selling
Investor
Value
Shares
Weight
Change
